Coronavirus | Global Biodefense

Menu

Latest stories

Middle Eastern Respiratory Syndrome virus particles

Adaptive Evolution of MERS-CoV to Infect Different Species

MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments

Experimental MERS Antibody Therapeutics Enter Clinical Trial

More on pathogens and preparedness

BARDA Backs Antibody Therapy Against MERS Virus

by Global Biodefense August 22, 2016, 8:46 pm
First-In-Human Study of MERS Vaccine Completes Enrollment

by Global Biodefense August 18, 2016, 10:38 am
NIH Evaluating New Antibody Treatment for MERS-CoV
MERS-CoV Less Virulent During Outbreak?

by Global Biodefense March 7, 2016, 7:47 am
MERS-CoV Likely Began in Bats, Moved to Camels, Then People

by Global Biodefense March 1, 2016, 12:03 pm
Walter Reed Kicks Off Phase 1 MERS Vaccine Trial

by Global Biodefense February 17, 2016, 11:35 am
Inovio and GeneOne Kick Off MERS Vaccine Trial
Report Outlines Framework for Global Pandemic Preparedness

by Global Biodefense January 13, 2016, 9:42 am
New Vaccine Against MERS Tested on Dromedary Camels

by Global Biodefense December 18, 2015, 10:13 am
Rapid Medical Countermeasure Response to Infectious Diseases

by Global Biodefense October 19, 2015, 11:50 am
Kenya: MERS Virus Widespread in Camels
Notable Contracts: BioFire Respiratory Panels for NAMRU-6

by Global Biodefense October 13, 2015, 9:15 am

Congratulations. You've reached the end of the internet.

Back to Top

Close

close